Abstract
AbstractThe chemoprofile of willow bark (Salix cortex) for pharmaceutical use was investigated using a combination of in vitro bioassays and analytical techniques. Salicylates were isolated by means of (semi‐)preparative HPLC, and their structure was elucidated by means of LC‐MS and 1D/2D‐NMR experiments. Bioactivity assays identified key compounds of selected Salix extracts contributing to the overall anti‐inflammatory potential. Finally, these phytochemicals were mapped quantitatively by means of LC‐MS/MS.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
